Liang Cheng: An exciting time to study bladder cancer
Liang Cheng shared on LinkedIn:
“I am very happy to know that our collaborative research on neuroendocrine bladder cancer may be accepted by Clinical Cancer Research after several rounds of revision. So much progress has been made since we published our article ‘Understanding the Genetic Landscape of Small Cell Carcinoma of the Urinary Bladder’ in JAMA Oncology a few years ago. This is an exciting time to study bladder cancer.”
Source: Liang Cheng/LinkedIn
Other posts featuring Liang Cheng on OncoDaily.
Liang Cheng is a Professor and Vice Chair for Translational Research at The Warren Alpert Medical School of Brown University. He serves as the Director of Anatomic Pathology and Molecular Pathology at Lifespan Academic Medical Center. His research is focused on translational studies of genitourinary cancers and the molecular diagnostics of solid tumors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023